Invesco Pharmaceuticals ETF (PJP) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores PJP 6.5 out of 10 — highest on Growth (9.1), lowest on Quality (4.7). It trades at 22.7 times earnings, against its own median of 20.8. Its ten largest holdings are 50% of the fund.
What stands out in PJP's data
Pharmaceutical companies, selected through a core index.
Analysts see faster earnings growth ahead than for most pharma peers — a bet on the pipeline.
A growth estimate of 33% tops the category median of 20% and the fund's own historical median of 7%. Holdings 27 names, with an expense ratio of 0.58%.
A focused sleeve for a portfolio that wants targeted pharma exposure.
Why did PJP move this week? It rose 1.7% in the week to October 9, 2026 — Abbvie and Gilead Sciences drove it
PJP rose 1.7% in the week to October 9, 2026. The holdings that moved it most were Abbvie (+5.2%), Gilead Sciences (+4.4%) and Prestige Brands (+6.6%); Travere Therapeutics (−8.4%) pushed the other way.
How is PJP rated? ETF Copilot scores Invesco Pharmaceuticals ETF (PJP) 6.5 out of 10
As of October 9, 2026, ETF Copilot scores Invesco Pharmaceuticals ETF (PJP) 6.5 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 6.5 / 10
- Growth: 9.1 / 10
- Value: 5.4 / 10
- Risk: 7.8 / 10
- Quality: 4.7 / 10
- Return: 5.0 / 10
PJP is ranked #9 of 10 in ETF Copilot's Growth list.
Is PJP expensive right now? It trades at 22.7 times earnings, against its own median of 20.8
As of October 9, 2026, PJP is more expensive than 71% of its own last 9 years.
Trailing 12 months, built from PJP's holdings. How we calculate this →
What's inside PJP?
What's inside PJP: Size (Large 52%, Mid 20%, Small 28%); Geography (International 6%, US 94%).
What are PJP's top holdings? The ten largest are 50% of the fund
Abbvie, Gilead Sciences, Pfizer, Eli Lilly, Johnson & Johnson, Amgen, Merck, Abbott Laboratories, Amneal Pharmaceuticals and Ligand Pharmaceuticals are PJP's largest holdings, in that order.
More concentrated than 64% of Health & Biotech ETFs.
Half of PJP's weight sits in its 10 largest positions, and once those weights are taken into account it behaves like 24 equally weighted holdings.
What is PJP's expense ratio? 0.58% a year
As of October 9, 2026, PJP charges 0.58% a year, yields 0.91% and holds $540M in assets across 27 positions.
| Measure | PJP |
|---|---|
| Expense ratio | 0.58% |
| Dividend yield | 0.91% |
| Assets under management | $540M |
| Holdings | 27 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “Invesco Pharmaceuticals ETF (PJP) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/pjp
ETF Copilot Pro unlocks PJP's price and what each holding weighs.
Try Pro free →